MONTREAL, July 03, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical…
Offer of US$3.01 in cash plus one contingent value right for potential additional aggregate payments of up to US$1.19 per…